Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Adgey

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
QJM : Monthly Journal of the Association of Physicians|December 18, 2001
Suspected angina pectoris: a rapid-access chest pain clinicJ P Dougan, T P Mathew, J W Riddell, et al.
British Heart Journal|April 1, 1986
Deaths from ischaemic heart disease in BelfastW J McIlwaine, M D Donnelly, M Mallaghan, et al.
Pacing and Clinical Electrophysiology : PACE|October 10, 2013
Low-tilt monophasic and biphasic waveforms compared with standard biphasic waveforms in the transvenous defibrillation of ventricular fibrillationJohan R Bennett, Karen M Darragh, Simon J Walsh, et al.
British Medical Journal (Clinical Research Ed.)|June 25, 1988
A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarctionA J McNeill, J S Shannon, S R Cunningham, et al.
Heart (British Cardiac Society)|January 29, 1999
Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarctionJ K French, I T Straznicky, B J Webber, et al.
The Quarterly Journal of Medicine|June 1, 1991
Thrombolytic therapy within one hour of the onset of acute myocardial infarctionA J McNeill, D J Flannery, C M Wilson, et al.
Lancet (London, England)|July 21, 1990
Transient release of lipid peroxides after coronary artery balloon angioplastyM J Roberts, I S Young, T G Trouton, et al.
British Heart Journal|April 1, 1989
A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarctionA J McNeill, S R Cunningham, D J Flannery, et al.
Circulation|October 23, 1997
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial InvestigatorsH D White, P E Aylward, M J Frey, et al.
The American Journal of Cardiology|November 24, 1999
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B InvestigatorsC M Gibson, C P Cannon, S A Murphy, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
QJM : Monthly Journal of the Association of Physicians|December 18, 2001
Suspected angina pectoris: a rapid-access chest pain clinicJ P Dougan, T P Mathew, J W Riddell, et al.
British Heart Journal|April 1, 1986
Deaths from ischaemic heart disease in BelfastW J McIlwaine, M D Donnelly, M Mallaghan, et al.
Pacing and Clinical Electrophysiology : PACE|October 10, 2013
Low-tilt monophasic and biphasic waveforms compared with standard biphasic waveforms in the transvenous defibrillation of ventricular fibrillationJohan R Bennett, Karen M Darragh, Simon J Walsh, et al.
British Medical Journal (Clinical Research Ed.)|June 25, 1988
A randomised dose ranging study of recombinant tissue plasminogen activator in acute myocardial infarctionA J McNeill, J S Shannon, S R Cunningham, et al.
Heart (British Cardiac Society)|January 29, 1999
Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarctionJ K French, I T Straznicky, B J Webber, et al.
The Quarterly Journal of Medicine|June 1, 1991
Thrombolytic therapy within one hour of the onset of acute myocardial infarctionA J McNeill, D J Flannery, C M Wilson, et al.
Lancet (London, England)|July 21, 1990
Transient release of lipid peroxides after coronary artery balloon angioplastyM J Roberts, I S Young, T G Trouton, et al.
British Heart Journal|April 1, 1989
A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarctionA J McNeill, S R Cunningham, D J Flannery, et al.
Circulation|October 23, 1997
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial InvestigatorsH D White, P E Aylward, M J Frey, et al.
The American Journal of Cardiology|November 24, 1999
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B InvestigatorsC M Gibson, C P Cannon, S A Murphy, et al.
Pageof 20